Increased serum pentraxin-3 level predicts poor prognosis in patients with colorectal cancer after curative surgery, a cohort study

Pentraxin-3 (PTX3) is a glycoprotein involved in inflammation and immune regulation of cancer. The aim of this study was to evaluate the serum PTX3 level in patients with colorectal cancer (CRC) and analyze its prognostic significance. A total of 263 consecutive patients underwent radical resection...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Bin, Zhao, Yangying, Guo, Lianrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200527/
https://www.ncbi.nlm.nih.gov/pubmed/30290589
http://dx.doi.org/10.1097/MD.0000000000011780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200527/
https://www.ncbi.nlm.nih.gov/pubmed/30290589
http://dx.doi.org/10.1097/MD.0000000000011780

Ejemplares similares